NYSE: NGVTIngevity Corp Stock
$48.23-0.67 (-1.37%)
Updated Apr 24, 2024
NGVT Price
$48.23
Fair Value Price
N/A
Market Cap
$1.75B
52 Week Low
$36.66
52 Week High
$72.76
P/E
-321.53x
P/B
2.77x
P/S
1.01x
PEG
N/A
Dividend Yield
N/A
Revenue
$1.69B
Earnings
-$5.40M
Gross Margin
27.9%
Operating Margin
4.92%
Profit Margin
-0.3%
Debt to Equity
3.16
Operating Cash Flow
$205M
Beta
1.25
Next Earnings
May 2, 2024
Ex-Dividend
N/A
Next Dividend
N/A
NGVT Overview
Ingevity Corporation manufactures specialty chemicals and activated carbon materials. Its Performance Chemicals segment manufactures chemicals used in processes such as asphalt paving, oil exploration and production, agrochemicals, adhesives, lubricants, and publication inks. The Performance Materials segment offers carbon products used in automobiles. Ingevity was founded in 1964 and is headquartered in North Charleston, SC.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NGVT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
NGVT is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
NGVT is good value based on its book value relative to its share price (2.77x), compared to the US Specialty Chemicals industry average (3.36x)
P/B vs Industry Valuation
NGVT is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more NGVT due diligence checks available for Premium users.
Be the first to know about important NGVT news, forecast changes, insider trades & much more!
NGVT News
Valuation
NGVT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-321.53x
Industry
30.27x
Market
41.27x
NGVT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.77x
Industry
3.36x
NGVT is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
NGVT's financial health
Profit margin
Revenue
$371.7M
Net Income
-$116.8M
Profit Margin
-31.4%
NGVT's Earnings (EBIT) of $83.20M... subscribe to Premium to read more.
Interest Coverage Financials
NGVT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$2.6B
Liabilities
$2.0B
Debt to equity
3.16
NGVT's short-term assets ($658.60M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NGVT's long-term liabilities ($1.63B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NGVT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
NGVT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$44.6M
Investing
-$21.0M
Financing
-$6.5M
NGVT's operating cash flow ($205.10M)... subscribe to Premium to read more.
Debt Coverage Financials
NGVT vs Specialty Chemical Stocks
Ingevity Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.